A Study of ABT-199 (Venetoclax) for Cutaneous T Cell Lymphoma (CTCL)
Clinical trial NCT04171791 · COMPLETED
Trial details
- NCT number
- NCT04171791
- Sponsor
- Yale University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-15
- Primary completion
- 2021-02-10
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.